Author

Rahul Jain

Institutions: Translational Health Science and Technology Institute, Medidata (United States)

Observed institutions: Translational Health Science and Technology Institute, Dassault Systèmes (United States), Medidata (United States)

ORCID: 0009-0005-8848-658X

Observed ORCID: 0009-0005-8848-658X

OpenAlex ID: A5029964323

Cytokine release syndrome risk model with T-cell engaging therapies

2025 · Pénélope Lafeuille, William A. Blumentals, et al. · Cytotherapy · 4

Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis

2024 · Jacob Aptekar, Rahul Jain, et al. · Lung Cancer · 3

Association between treatment (tx) response and PFS and OS in R/R chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A 12-month landmark (LM) meta-analysis.

2024 · Jennifer Ann Woyach, Xin Wang, et al. · Journal of Clinical Oncology · 1

Immune Checkpoint Inhibitors and the Risk of Cardiovascular Adverse Events: A Pooled Clinical Trial Database Analysis

2023 · Kayleen Ports, Rahul Jain, et al. · Blood · 1

Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies

2023 · Penelope Lafeuille, William Blumentals, et al. · Blood · 1

HSR22-179: Treatment Patterns of Patients With Soft Tissue Sarcoma Progressing to Third Line of Therapy

2022 · Vicki K. Wing, Philippe Martin, et al. · Journal of the National Comprehensive Cancer Network · 1

Progression‐free survival and overall survival in the first‐line treatment of BRCA wild‐type advanced epithelial ovarian cancer: An analysis of patient‐level data pooled from historical clinical trials

2026 · Le Su, Mehmet Burcu, et al. · Cancer

Development and external validation of deep learning models for spontaneous preterm birth prediction from mid-trimester cervical ultrasound

2026 · Radhika Chanian, Divyanshu Mishra, et al. · medRxiv

Efficacy of tocilizumab in resolving chimeric antigen receptor T-cell (CAR T)–induced cytokine release syndrome (CRS): A pooled clinical trial (CT) analysis of patients (pts) with B-cell lymphoma (BCL).

2026 · Soon Jye Kho, Rahul Jain, et al. · Journal of Clinical Oncology

Machine learning approach for detection of MACE events within clinical trial data

2024 · John A. Spanias, Robbie Buderi, et al. · Journal of Biopharmaceutical Statistics

EPR22-107: Evaluation of Early Risk of Moderate-to-Severe Cytokine Release Syndrome (CRS) Induced by CAR T-cell Therapy Using Pooled Clinical Trial Data

2022 · Robert R Buderi, Emelly Rusli, et al. · Journal of the National Comprehensive Cancer Network

Works count: 11

Citation count: 11

H-index: 2

I10-index: